IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v7y2016i1d10.1038_ncomms12329.html
   My bibliography  Save this article

EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance

Author

Listed:
  • C. Depner

    (Institute of Neuropathology, University of Giessen)

  • H. zum Buttel

    (Institute of Cell Biology and Neuroscience and Buchmann Institute for Molecular Life Sciences (BMLS), University of Frankfurt)

  • N. Böğürcü

    (Institute of Neuropathology, University of Giessen)

  • A. M. Cuesta

    (Institute of Cell Biology and Neuroscience and Buchmann Institute for Molecular Life Sciences (BMLS), University of Frankfurt)

  • M. R. Aburto

    (Institute of Cell Biology and Neuroscience and Buchmann Institute for Molecular Life Sciences (BMLS), University of Frankfurt
    Focus Program Translational Neurosciences (FTN), University of Mainz)

  • S. Seidel

    (Institute of Neuropathology, University of Giessen)

  • F. Finkelmeier

    (Institute of Neuropathology, University of Giessen)

  • F. Foss

    (Institute of Cell Biology and Neuroscience and Buchmann Institute for Molecular Life Sciences (BMLS), University of Frankfurt
    Focus Program Translational Neurosciences (FTN), University of Mainz)

  • J. Hofmann

    (Institute of Cell Biology and Neuroscience and Buchmann Institute for Molecular Life Sciences (BMLS), University of Frankfurt)

  • K. Kaulich

    (Heinrich Heine University of Düsseldorf, Düsseldorf and German Cancer Consortium (DKTK))

  • S. Barbus

    (German Cancer Research Center (DKFZ))

  • M. Segarra

    (Institute of Cell Biology and Neuroscience and Buchmann Institute for Molecular Life Sciences (BMLS), University of Frankfurt)

  • G. Reifenberger

    (Heinrich Heine University of Düsseldorf, Düsseldorf and German Cancer Consortium (DKTK))

  • B. K. Garvalov

    (Institute of Neuropathology, University of Giessen)

  • T. Acker

    (Institute of Neuropathology, University of Giessen)

  • A. Acker-Palmer

    (Institute of Cell Biology and Neuroscience and Buchmann Institute for Molecular Life Sciences (BMLS), University of Frankfurt
    Focus Program Translational Neurosciences (FTN), University of Mainz
    Max Planck Institute for Brain Research)

Abstract

Diffuse invasion of the surrounding brain parenchyma is a major obstacle in the treatment of gliomas with various therapeutics, including anti-angiogenic agents. Here we identify the epi-/genetic and microenvironmental downregulation of ephrinB2 as a crucial step that promotes tumour invasion by abrogation of repulsive signals. We demonstrate that ephrinB2 is downregulated in human gliomas as a consequence of promoter hypermethylation and gene deletion. Consistently, genetic deletion of ephrinB2 in a murine high-grade glioma model increases invasion. Importantly, ephrinB2 gene silencing is complemented by a hypoxia-induced transcriptional repression. Mechanistically, hypoxia-inducible factor (HIF)-1α induces the EMT repressor ZEB2, which directly downregulates ephrinB2 through promoter binding to enhance tumour invasiveness. This mechanism is activated following anti-angiogenic treatment of gliomas and is efficiently blocked by disrupting ZEB2 activity. Taken together, our results identify ZEB2 as an attractive therapeutic target to inhibit tumour invasion and counteract tumour resistance mechanisms induced by anti-angiogenic treatment strategies.

Suggested Citation

  • C. Depner & H. zum Buttel & N. Böğürcü & A. M. Cuesta & M. R. Aburto & S. Seidel & F. Finkelmeier & F. Foss & J. Hofmann & K. Kaulich & S. Barbus & M. Segarra & G. Reifenberger & B. K. Garvalov & T. A, 2016. "EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance," Nature Communications, Nature, vol. 7(1), pages 1-15, November.
    • Handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms12329
    DOI: 10.1038/ncomms12329
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms12329
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/ncomms12329?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms12329. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.